Risk of low-energy hip fracture in adherent users of statins compared with adherent users of antihypertensive drugs and with randomly selected population cohort.

*8 persons missing data on region of residence excluded.HR = Hazard ratio.†Age, coronary heart disease, rheumatoid arthritis, use of anti-diabetics, and hormone replacement therapy at cohort entry in the statin versus hypertension cohort analyses.‡Variables mentioned above plus diuretics, beta blockers, calcium channel blockers, and angiotensinconverting enzyme inhibitors or angiotensin receptor blockers at cohort entry in the statin versus population cohort analyses.